GlassScriptPhysician profile
Amanulla Khaji
NPI 1083940985
$15,413.07
in general payments reported to CMS, 2019-2025
31 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,373 · 2020: $1,193 · 2021: $287 · 2022: $380 · 2023: $3,521 · 2024: $1,205 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,028 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,027.89 |
| Travel and Lodging | $1,152.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,394.45 | 2019-2020 | |
| Biotronik INC. | $3,341.95 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $2,270.64 | 2019-2022 | |
| Zoll Respicardia, INC. | $1,334.94 | 2023 | Remede System |
| Medtronic, INC. | $1,280.51 | 2021-2025 | Micra, Onyx Frontier, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $694.75 | 2019-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medical Device Business Services, INC. | $661.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $441.81 | 2019-2025 | Farxiga, Brilinta |
| Biosense Webster, INC. | $363.50 | 2019-2025 | Qdot Micro Catheter, Carto 3 |
| Amgen INC. | $268.36 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $222.68 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.78 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $156.76 | 2019-2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $127.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $101.01 | 2023-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $90.79 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.06 | 2019-2025 | Jardiance |
| Pfizer INC. | $68.42 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $59.55 | 2019-2020 | |
| Amarin Pharma, INC. | $45.92 | 2019-2021 | |
| Scpharmaceuticals INC. | $38.10 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $24.18 | 2024 | Arcalyst |
| Lilly USA, LLC | $20.67 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $20.59 | 2025 | Inspire |
| Siemens Medical Solutions USA, INC. | $20.44 | 2024 | Syngo Dynamics |
| Esperion Therapeutics, INC. | $20.10 | 2025 | Nexletol |
| Surmodics, INC. | $16.84 | 2024 | Pounce Thrombectomy |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Preventice Services, LLC | $14.27 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.02 | 2019 | |
| Acarix USA INC. | $11.49 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanulla Khaji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.